Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-18-007647

Chief Executive Officer acquired 30,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FLESHER GREGORY J. Chief Executive Officer 2018-03-13 Grant or award +30,700 146,556 D
Derivatives
FLESHER GREGORY J. Chief Executive Officer 2018-03-13 Grant or award · Stock Option (Right to Buy) +56,500 56,500 D
Loading xslF345X03/doc4.xml…